Fibronectin is chemotactic for CT 26 colon carcinoma cells: Sub-lines selected for increased chemotaxis to fibronectin display decreased tumorigenicity and lung colonization

Clinical and Experimental Metastasis

Volumn 16, Issue 8, 1998, Pages 683-691

  Geng, Li ^a   Ali, Selman A ^a   Marshall, John F ^b   Mackay, C Logan ^a   Hart, Ian R ^b   Delcommence, Marc ^c   Streuli, Charles H ^c   Rees, Robert C ^a  

^a NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Chemotaxis; Colon cancer; Fibronectin; Metastasis; Tumorigenicity

Indexed keywords

FIBRONECTIN; INTEGRIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL ADHESION; CHEMOTAXIS; COLON ADENOCARCINOMA; CONTROLLED STUDY; FLOW CYTOMETRY; NONHUMAN; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; CELL ADHESION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CHEMOTACTIC FACTORS; CHEMOTAXIS; COLLAGEN; COLONIC NEOPLASMS; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTINS; LAMININ; LUNG NEOPLASMS; MICE; TUMOR CELLS, CULTURED;

EID: 0032425583     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006572526520     Document Type: Article

References (39)

1. 1. Liotta LA, Rao CN and Barsky SH, 1983, Tumour invasion and the extracellular matrix. Lab Invest, 49, 636-9.
2. 2. Gui GPH, Puddefoot JR, Vision GP, et al. 1997, Altered cell-matrix contact: a prerequisite for breast cancer metastasis? Br J Cancer, 75, 623-33.
3. 3. Ruoslahti E, 1988, Fibronectin and its receptors. Ann Rev Biochem, 57, 375-413.
4. 4. Ruoslahti E, 1994, Fibronectin and its alpha (5) beta (1) integrin receptor in malignancy. Inv Metastasis, 14, 87-97.
5. 5. Yamada KM, Yamada SS and Pastan I, 1976, Cell surface protein partially restores morphology, adhesiveness, and contact inhibition of movement to transformed fibroblast. Proc Natl Acad Sci USA, 73, 1217-21.
6. 6. Akiyama KM, Hasegawa E, Hasegawa T and Yamada KM, 1986, Characterization of a 140 kD avian cell surface antigen as fibronectin-binding molecule. J Cell Biol, 102, 442-8.
7. 7. Takada Y, Wayner EA, Carter WG and Hemler ME, 1988, Extracellular matrix receptors, ECMRII and ECMRI, for collagen and fibronectin, correspond to VLA-2 and VLA-3 in the VLA family of heterodimers. J Cell Biochem, 37, 385-93.
8. 8. Guan JL and Hynes RO, 1990, Lymphoid cells recognize an alternatively spliced fibronectin via the integrin receptor alpha 4/beta1. Cell, 60, 53-61.
9. 9. Phillips DR, Charo IF, Paris LV and Fitzgerald LA, 1988, The platelet membrane glycoprotein Iib-IIIA complex. Blood, 71, 831-84.
10. 10. Hemler ME, 1990, VLA proteins in the integrin family. Ann Rev Immunol, 8, 365-400.
11. 11. Planetfaber LC and Hynes RO, Changes in integrin receptors on oncogenically transformed cells. Cell, 56, 281-90.
12. 12. Giancotti F and Ruoslahti E, 1991, Elevated levels of α5β1 fibronectin receptor suppress the transformed phenotype in CHO cells. Cell, 60, 849-59.
13. 13. Stallmach A, Vonlampe B, Matthes G, et al. 1992, Differential loss of integrin adhesion molecules on human colonic epithelial cells during the benign to malignant tumour transformation. Gut, 33, 342-6.
14. 14. Stallmach A, Vonlape B, Orzechowski HD, et al. 1994, Increased fibronectin-receptor expression in colon carcinoma-derived HT 29 cells decreases tumourigenicity in nude mice. Gastroenterol, 106, 19-27.
15. 15. Albini A, Iwamoto Y, Kleinman HK, et al. 1987, A rapid in vitro assay for quantitating the invasive potential of tumour cells. Cancer Res, 47, 3239-45.
16. 16. Simon N, Noel A and Floidart JM, 1992, Evaluation of in vitro reconstituted basement membrane assay to assess the invasiveness of tumour cells. Inv Metastasis, 12, 156-67.
17. 17. Fong CJ, Sutkoski DM, Kozlowski JW and Lee C, 1992, Utilization of the Boyden chamber to further characterize in vitro migration and invasion of benign and malignant human prostatic epithelial cells. Inv Metastasis, 12, 264-74.
18. 18. Corbet TH, Griswold DP Jr, Robert BT, et al. 1975, Tumour induction relationships in development of transplantable cancer of the colon in mice for chemotherapy assay with a note on carcinogen structure. Cancer Res, 35, 2434-9.
19. 19. Delcommenne M and Streuli CH, 1998, Production of rat monoclonal antibodies specific for mouse integrins. In: Howlett A, ed. Integrin Protocols. The Human Press Inc., USA (in press).
20. 20. Searles GE, Dixon WT, Thomas PD and Jimbow K, 1995, Divalent cations control cell-substrate adhesion and laminin expression in normal and malignant human melanocyte in early and late stages of cellular differentiation. J Invest Dermatol, 105, 301-8.
21. 21. Danen EHJ, Aota SI, van Kraats AA, et al. 1995, Requirement for the synergy site for cell adhesion to fibronectin depends on the action state of integrin α5β1. J Biol Chem, 270, 21612-18.
22. 22. Youngs SJ, Ali SA, Taub DD and Rees RC, 1997, Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer, 71, 1-10.
23. 23. Smith JW, 1994, The structural basis of integrin-ligand (RGD) interaction. In: Cheresh DA and Mecham RP, eds. Integrins: Molecular and Biological Response to the Extracellular Matrix. New York: Academic Press, pp. 1-31.
24. 24. Fidler IJ and Hart IR, 1982, Biological diversity in metastatic neoplasm origins and implications. Science, 217, 998-1003.
25. 25. Heppner GH, 1984, Tumour heterogeneity. Cancer Res, 44, 2259-65.
26. 26. Nicolson GL, 1984, Tumour progression, oncogenes and the evolution of metastatic phenotypic diversity. Clin Exp Metastasis, 2, 85-105.
27. 27. Nicolson GL, 1987, Tumour cells instability, diversification and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res, 47, 1473-87.
28. 28. Van den Hooff A, 1983, Connective tissue changes in cancer. Int Rev Conn Tissue Res, 10, 395-432.
29. 29. Li ML, Aggeler J, Farson DA, et al. 1987, Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells. Proc Natl Acad Sci USA, 84, 136-40.
30. 30. Urtreger AJ, Ladeda VE, Puricelli LI, et al. 1997, Modulation of fibronectin expression and proteolytic activity associated with the invasion and metastatic phenotype in two new murine mammary tumour cell lines. Int J Oncol, 11, 489-96.
31. 31. Mackay CR and Imhof BA, 1993, Cell adhesion in the immune system. Immunol Today, 14, 99-102.
32. 32. Davis GE and Camarillo CW, 1993, Regulation of integrin-mediated myeloid cell adhesion to fibronectin. J Immunol, 151, 7138-50.
33. 33. Hara M, Yaar M, Tang A, et al. 1994, Role of integrins in melanocyte attachment and dextricity. J Cell Sci, 107, 2739-48.
34. 34. Schreiner C, Fisher M, Hussein S and Juliano RL, 1991, Increased tumourigenicity of fibronectin receptor deficient Chinese hamster ovary variants. Cancer Res, 51, 1738-44.
35. 35. Varner JA, Emerson DA and Juliano RL, 1995, Integrin α5β1 expression negatively regulates cell growth: reversal by attachment to fibronectin. Mol Biol Cell, 6, 725-40.
36. 36. Delsal G, Ruaro ME, Philipson L and Schneider C, 1992, The growth arrest-specific gene, gas-1, is involved in growth suppression. Cell, 70, 595-607.
37. 37. Delsal G, Collavin L, Rurao ME, et al. 1994, Structure, function, and chromosome mapping of the growth suppressing human homology of the murine gas-1 gene. Proc Natl Acad Sci USA, 91, 1848-52.
38. 38. Abe Y, Tsutsui T, Mu J, et al. 1997, A defect in cell-to-cell adhesion via integrin-fibronectin interactions in a highly metastatic tumour cell line. Jpn J Cancer Res, 88, 64-71.
39. 39. Ruoslahti E, 1992, Control of cell motility and tumour invasion by extracellular matrix interactions. Br J Cancer, 66, 239-42.